Global Plasma Therapy Market Size, Status and Forecast 2021-2027

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
North America is the largest consumption place, with a consumption market share nearly 53.54% in 2018. More specifically, the market size of plasma therapy in North America is approximately105.53 M USD. Following North America, Europe is the second largest consumption place with the consumption market share of 26.10% in 2018. Besides，Market competition is intense. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry.

Market Analysis and Insights: Global Plasma Therapy Market
The global Plasma Therapy market size is projected to reach US$ 472.2 million by 2027, from US$ 242.3 million in 2020, at a CAGR of 10.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasma Therapy market.

Global Plasma Therapy Scope and Market Size
Plasma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.

Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics